Phase 3
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Rectal Cancer
Both
Rectal Cancer
Trial Information
Inclusion Criteria:
- Mid- and low-lying rectal cancer (between 0 and 11 cm from the anal margin)
- Histology of adenocarcinoma
Exclusion Criteria:
- Locally advanced disease (T4)
- Emergency surgery
- Rectal cancer over familial colic polyposis
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Lymph nodes isolated, circumferential margin involved, rate of complications and length of stay
Outcome Time Frame:
1 month
Safety Issue:
Yes
Authority:
Spain: Ethics Committee
Study ID:
D-08-00770
NCT ID:
NCT00782457
Start Date:
January 2002
Completion Date:
December 2010
Related Keywords:
- Rectal Cancer
- Rectal Neoplasms
Name | Location |
|---|
